Hawaii Pacific Neuroscience, 2230 Liliha st 104 — Honolulu, Hawaii

Hawaii Pacific Neuroscience, 2230 Liliha st 104 is a clinical research site located in Honolulu, Hawaii, United States 96817.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Hawaii Pacific Neuroscience, 2230 Liliha st 104 has participated in 1 clinical trials.

Therapeutic areas: Alzheimers Disease.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hawaii Pacific Neuroscience, 2230 Liliha st 104?

Hawaii Pacific Neuroscience, 2230 Liliha st 104 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hawaii Pacific Neuroscience, 2230 Liliha st 104 conducted?

Hawaii Pacific Neuroscience, 2230 Liliha st 104 has 1 clinical trials on record. Their work covers Alzheimers Disease.

Is Hawaii Pacific Neuroscience, 2230 Liliha st 104 accredited by Crixeo Health?

Hawaii Pacific Neuroscience, 2230 Liliha st 104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hawaii Pacific Neuroscience, 2230 Liliha st 104?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.